Skip to main content
Sunday, November 15, 2026 AI-Powered Newsroom — All facts, no faction
PB

Political Bytes

Where the left meets the right in an unbiased dialogue
Policy & Law

Sen. Cassidy Says RFK Jr. Failing on Health Goals, Questions FDA Nominee Overton

The HELP Committee chairman cites measles resurgence and stalled processed food reforms while weighing confirmation of Dr. Heidi Overton.

Senator Bill Cassidy, R-La., speaks during an interview on Face the Nation.
Photo: U.S. Senate (Public Domain) via Wikimedia Commons
⚡ The Bottom Line

The Senate is approaching a critical deadline with only three weeks left in the calendar year to confirm key health officials and address budgetary issues. The fate of Dr. Heidi Overton's nomination as FDA commissioner rests with the HELP Committee, with a vote scheduled for Wednesday. Cassidy indicated that the outcome remains uncertain due to lingering concerns about her policy record and the...

Read full analysis ↓

Senator Bill Cassidy, Republican of Louisiana and chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, stated that U.S. health policy has seen significant setbacks in disease control and food safety under Secretary Robert F. Kennedy Jr. Speaking on "Face the Nation" with Margaret Brennan, Cassidy addressed the loss of measles elimination status, the confirmation prospects for FDA nominee Dr. Heidi Overton, and the impasse over Social Security reform before the new Congress convenes in January.

Cassidy, a physician, emphasized the public health implications of the recent loss of measles elimination status, a development reported by KFF. He argued that individual vaccination choices impact vulnerable populations, including infants and the immunocompromised. While acknowledging ongoing communication with CDC Director Dr. Schwartz, Cassidy indicated that public health messaging requires more forceful leadership to protect those unable to receive vaccines.

What the Right Is Saying

Senator Cassidy, a Republican, expressed significant disappointment in Secretary Kennedy's performance, noting that Kennedy has broken promises regarding oversight and progress on ultra-processed foods. Cassidy stated that Kennedy's claim that the Senate no longer has leverage over him is an attempt to cover up failures. He noted that many constituents, including 'MAHA' (Make America Healthy Again) advocates who initially supported Kennedy, are disappointed by the lack of progress on food safety and the resurgence of measles.

Cassidy suggested that President Trump should consider replacing Kennedy to protect his own political legacy, arguing that higher healthcare costs and disease outbreaks are detrimental to the administration's goals. Regarding impeachment, Cassidy dismissed the possibility, stating that he didn't see an impeachable offense and that the decision is ultimately up to the president.

Regarding the FDA nomination of Dr. Heidi Overton, Cassidy expressed uncertainty about her confirmation. He cited concerns raised by Senators Susan Collins and Lisa Murkowski regarding flavored vapes, political pressure on scientific review, and the approval of mifepristone. Cassidy noted that while Overton's role in childhood vaccine policy was problematic, there is a trade-off between seeking a 'perfect' candidate and ensuring a stable, independent FDA commissioner before the year ends.

What the Left Is Saying

Progressive Democrats have intensified calls for accountability within the Department of Health and Human Services (HHS). Senator Angela Alsobrooks and Senator Raphael Warnock have stated that Secretary Kennedy must resign or be fired.

Incoming Senator Dr. Annie Andrews of South Carolina ran on a platform of impeaching Kennedy. However, Senator Cassidy dismissed the likelihood of impeachment proceedings, stating that he didn't see an impeachable offense and that the decision is ultimately up to the president.

What the Numbers Show

Cassidy highlighted several key metrics and timelines relevant to current health and economic policy. He confirmed that the U.S. has officially lost its status as a country where measles is eliminated, with infants currently dying from the disease. He noted that there are approximately 20 working days remaining in the year to address major legislative items, including defense funding, government funding, and Social Security reform.

On Social Security, Cassidy stated that the program is projected to become insolvent in six years. He proposed a bipartisan plan that would borrow $1.5 trillion to create a separate investment fund, aiming to cover up to 70% of the projected debt over six decades. Cassidy criticized Senate Finance Committee Ranking Member Ron Wyden for refusing to advance the bill, despite Cassidy's assertion that 60 votes are available in the Senate and the President has committed to signing it. Cassidy noted that Wyden previously voted for a similar investment strategy for the federal railroad retirement system under President George W. Bush.

The Bottom Line

The Senate is approaching a critical deadline with only three weeks left in the calendar year to confirm key health officials and address budgetary issues. The fate of Dr. Heidi Overton's nomination as FDA commissioner rests with the HELP Committee, with a vote scheduled for Wednesday. Cassidy indicated that the outcome remains uncertain due to lingering concerns about her policy record and the broader political dynamics within the committee.

Meanwhile, the impasse over Social Security reform highlights the deep partisan divide, even on issues with potential bipartisan support. Cassidy warned that neglecting Social Security's financial health poses a long-term risk to the country, comparing the program to a child that needs immediate care when it appears ill. The administration's response to the measles crisis and Kennedy's continued tenure will likely remain central points of contention as Democrats prepare to take the Senate majority in January.

Sources